Hikari Tsushin, Inc. Bristol Myers Squibb CO Transaction History
Hikari Tsushin, Inc.
- $1.47 Billion
- Q1 2025
A detailed history of Hikari Tsushin, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hikari Tsushin, Inc. holds 81,141 shares of BMY stock, worth $3.68 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
81,141
Previous 81,141
-0.0%
Holding current value
$3.68 Million
Previous $4.59 Million
7.82%
% of portfolio
0.34%
Previous 0.34%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,691Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.1M-
Vanguard Group Inc Valley Forge, PA191MShares$8.68 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.2 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.9 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.3 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.01 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...